179 related articles for article (PubMed ID: 29408713)
1. Synthesis, characterization, and in vitro cytotoxicity of fatty acyl-CGKRK-chitosan oligosaccharides conjugates for siRNA delivery.
El-Sayed NS; Sharma M; Aliabadi HM; El-Meligy MG; El-Zaity AK; Nageib ZA; Tiwari RK
Int J Biol Macromol; 2018 Jun; 112():694-702. PubMed ID: 29408713
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates.
Sharma M; El-Sayed NS; Do H; Parang K; Tiwari RK; Aliabadi HM
Sci Rep; 2017 Jul; 7(1):6093. PubMed ID: 28733622
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of chitosan conjugated GGRGDSK peptides as a cancer cell-targeting molecular transporter.
El-Sayed NS; Shirazi AN; El-Meligy MG; El-Ziaty AK; Nagieb ZA; Parang K; Tiwari RK
Int J Biol Macromol; 2016 Jun; 87():611-22. PubMed ID: 26976071
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
7. Chitosan combined with poly-L-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery.
Plianwong S; Opanasopit P; Ngawhirunpat T; Rojanarata T
Biomed Res Int; 2013; 2013():574136. PubMed ID: 23865058
[TBL] [Abstract][Full Text] [Related]
8. Target gene delivery from targeting ligand conjugated chitosan-PEI copolymer for cancer therapy.
Nam JP; Nah JW
Carbohydr Polym; 2016 Jan; 135():153-61. PubMed ID: 26453863
[TBL] [Abstract][Full Text] [Related]
9. Functionalized chitosan derivatives as nonviral vectors: physicochemical properties of acylated N,N,N-trimethyl chitosan/oligonucleotide nanopolyplexes.
Santos JC; Moreno PM; Mansur AA; Leiro V; Mansur HS; Pêgo AP
Soft Matter; 2015 Nov; 11(41):8113-25. PubMed ID: 26335751
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
[TBL] [Abstract][Full Text] [Related]
12. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
[TBL] [Abstract][Full Text] [Related]
13. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
[TBL] [Abstract][Full Text] [Related]
15. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Core-Shell Silica Nanoparticles with Large Radial Mesopores for siRNA Delivery.
Xiong L; Bi J; Tang Y; Qiao SZ
Small; 2016 Sep; 12(34):4735-42. PubMed ID: 27199216
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
[TBL] [Abstract][Full Text] [Related]
18. Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes.
Han L; Tang C; Yin C
Biomaterials; 2013 Jul; 34(21):5317-27. PubMed ID: 23591392
[TBL] [Abstract][Full Text] [Related]
19. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of N-furoyl chitosan and chito-oligosaccharides and evaluation of their antioxidant activity in vitro.
Zhao D; Wang J; Tan L; Sun C; Dong J
Int J Biol Macromol; 2013 Aug; 59():391-5. PubMed ID: 23664935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
